P300 in newly diagnosed non-dementing Parkinson's disease: Effect of dopaminergic drugs

Neurology India

Volumn 48, Issue 3, 2000, Pages 239-242

  Prabhakar, S ^a   Syal, P ^a   Srivastava, T ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Levodopa; P300; Parkinsonism

Indexed keywords

DOPAMINE; LEVODOPA; PROTEIN P300; ANTIPARKINSON AGENT;

ACTION POTENTIAL; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE DEFECT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMENTIA; DRUG ANTAGONISM; DRUG EFFECT; EVOKED RESPONSE; FEMALE; FOLLOW UP; HUMAN; IDIOPATHIC DISEASE; LATENT PERIOD; MALE; NEUROLOGIC EXAMINATION; PARKINSON DISEASE; TREATMENT OUTCOME; COGNITION; EVENT RELATED POTENTIAL; EVOKED AUDITORY RESPONSE; MENTAL HEALTH; MIDDLE AGED; PATHOPHYSIOLOGY; PREDICTION AND FORECASTING; PROGNOSIS; REACTION TIME;

ADULT; AGED; ANTIPARKINSON AGENTS; COGNITION; DEMENTIA; EVENT-RELATED POTENTIALS, P300; EVOKED POTENTIALS, AUDITORY; FEMALE; HUMANS; LEVODOPA; MALE; MENTAL STATUS SCHEDULE; MIDDLE AGED; PARKINSON DISEASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REACTION TIME;

EID: 0033623201     PISSN: 00283886     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. 'Frontal' cognitive function in patients with Parkinson's disease 'on' and 'off' levodopa
2. Cognitive deficits in the early stages of Parkinson's disease
3. How common is dementia in Parkinson's disease
4. Event related potentials, reaction time and cognitive state in patients with Parkinson's disease
5. Alteration in cognitive performance and affect arousal state during fluctuation in motor function in Parkinson's disease
6. Relationship of motor symptoms to intellectual deficits in Parkinson's disease
7. Cognition and the basal ganglia: Separating mental and motor components of performance in Parkinson's disease
8. Electrophysiological difference between demented and non-demented patients with Parkinson's disease
9. Parkinsonism: Onset, progression and mortality
10. 'Minimental state' - A practical method for grading the cognitive state of patients for the clinician
11. Studies of dementia, depression, electrophysiology and cerebrospinal fluid monoamine metabolite in patients with Parkinson's disease
12. Parkinson's disease, cognition and ageing. Clinical, neuropsychological, electrophysiological and cranial computerised tomographic assessment
13. Cognition in Parkinson's disease: An event related potential perspective
14. 300 and reaction time in Parkinson's disease
15. Dopaminergic induced changes in cognitive and motor processing in Parkinson's disease: An electrophysiological investigation
16. 300 abnormality in Parkinson's disease